The Diagnostic Conundrum and Treatment Dilemma of a Patient With a Rapidly Progressive Encephalopathy

The Neurohospitalist

Volumn 4, Issue 1, 2014, Pages 34-41

  Beatty, Christopher W ^a   Creutzfeldt, Claire J ^b   Davis, Arielle P ^b   Khot, Sandeep P ^b   Hoffer, Zachary ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

anti N methyl d aspartate receptor encephalitis; encephalitis; paraneoplastic; tuberculosis meningoencephalitis

Indexed keywords

EID: 84992804051     PISSN: 19418744     EISSN: 19418752     Source Type: Journal    
DOI: 10.1177/1941874413496792     Document Type: Article

References (27)

1. Roos KL Greenlee JE. Meningitis and encephalitis. Continuum (Minneap Minn). 2011; 17(5):1010–1023.
2. Tuzun E Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007; 13(5):261–271.
3. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006; 71(2-3):141–148.
4. Hristea A Olaru ID Baicus C Moroti R Arama V Ion M. Clinical prediction rule for differentiating tuberculous from viral meningitis. Int J Tuberc Lung Dis. 2012; 16(6):793–798.
5. Sutlas PN Unal A Forta H Senol S Kirbas D. Tuberculous meningitis in adults: review of 61 cases. Infection. 2003; 31(6):387–391.
6. Galimi R. Extrapulmonary tuberculosis: tuberculous meningitis new developments. Eur Rev Med Pharmacol Sci. 2011; 15(4):365–386.
7. Bernaerts A Vanhoenacker FM Parizel PM, et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol. 2003; 13(8):1876–1890.
8. Beattie GC Glaser CA Sheriff H, et al. Encephalitis with thalamic and basal ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses. Clin Infect Dis. 2013; 56(6):825–832.
9. Greenlee J Carroll KC. Cerebrospinal fluid in central nervous system infections. In: Scheld MW, Whitley RJ, Marra CM, eds. Infections of the Central Nervous System. Philadelphia, PA: Lippincott Williams & Wilkins; 2004;18.
10. Dinnes J Deeks J Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess. 2007; 11(3):1–196.
11. Verdon R Chevret S Laissy JP Wolff M. Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis. 1996; 22(6):982–988.
12. Thwaites GE Nguyen DB Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004; 351(17):1741–1751.
13. Dalmau J Tuzun E Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007; 61(1):25–36.
14. Dalmau J Gleichman AJ Hughes GH, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7(12):1091–1098.
15. Gable MS Sheriff H Dalmau J Tilley DH Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012; 54(7):899–904.
16. Gable MS Gavali S Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009; 28(12):1421–1429.
17. Pruss H Dalmau J Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010; 75(19):1735–1739.
18. Irani SR Bera K Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010; 133(pt 6):1655–1667.
19. Dalmau J Lancaster E Martinez-Hernandez E Rosenfeld MR Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10(1):63–74.
20. Titulaer MJ McCracken L Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157–165.
21. Iizuka T Sakai F Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008; 70(7):504–511.
22. Finke C Kopp UA Pruss H Dalmau J Wandinger KP Ploner CJ, Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012; 83(2):195–198.
23. Florance NR Davis RL Lam C, et al. Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis in Children and Adolescents. Ann Neurol. 2009; 66(1):11–88.
24. Sansing LH Tuzun E Ko MW Baccon J Lynch DR Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol. 2007; 3(5):291–296.
25. Hansen HC Klingbeil C Dalmau J Li W Weissbrich B Wandinger KP. Persistent intrathecal antibody synthesis 15 tears After recovering from anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol. 2013; 70(1):117–119.
26. Prüss H Finke C Höltje M, et al. NMDA receptor antibodies in herpes simplex encephalitis. Ann Neurol. 2012; 72(6):902–911.
27. Ishiura H Matsuda S Higashihara M, et al. Response of anti-NMDA receptor enchephalitis without tumor to immunotherapy including rituximab. Neurology. 2008; 71(23):1921–1923.